Switching immunosuppressive drugs in kidney transplant recipients: "show me the evidence".
Ansari
Mohammed Javeed
MJ
Sayegh
Mohamed H
MH
D016572:Cyclosporine / Q000627:therapeutic use; D004338:Drug Combinations; D016568:Drugs, Generic / Q000627:therapeutic use; D004655:Emulsions / Q000008:administration & dosage; D000068338:Everolimus; D019317:Evidence-Based Medicine; D006801:Humans; D007166:Immunosuppressive Agents / Q000493:pharmacokinetics / Q000627:therapeutic use*; D016030:Kidney Transplantation; D009173:Mycophenolic Acid / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives; D020123:Sirolimus / Q000031:analogs & derivatives / Q000627:therapeutic use; D013608:Tablets, Enteric-Coated; D016559:Tacrolimus / Q000008:administration & dosage
D004338:Drug Combinations; D016568:Drugs, Generic; D004655:Emulsions; D007166:Immunosuppressive Agents; D013608:Tablets, Enteric-Coated; D016572:Cyclosporine; D000068338:Everolimus; D009173:Mycophenolic Acid; D020123:Sirolimus; D016559:Tacrolimus